End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
659.7 INR | +1.99% | +2.35% | -8.73% |
Mar. 27 | Suven Pharmaceuticals Limited Announces Shifting of Registered Office | CI |
Mar. 05 | Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call |
Sales 2023 | 13.4B 161M | Sales 2024 * | 10.9B 131M | Capitalization | 168B 2.01B |
---|---|---|---|---|---|
Net income 2023 | 4.11B 49.33M | Net income 2024 * | 3.34B 40.08M | EV / Sales 2023 | 8.97 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 15.4 x |
P/E ratio 2023 |
29.2
x | P/E ratio 2024 * |
50.2
x | Employees | 1,193 |
Yield 2023 * |
0.36% | Yield 2024 * |
0.27% | Free-Float | 37.48% |
Latest transcript on Suven Pharmaceuticals Limited
1 day | +1.99% | ||
1 week | +2.35% | ||
Current month | -2.57% | ||
1 month | +3.09% | ||
3 months | -3.21% | ||
6 months | +16.07% | ||
Current year | -8.73% |
Managers | Title | Age | Since |
---|---|---|---|
Sudhir Singh
CEO | Chief Executive Officer | - | 23-09-28 |
Himanshu Agarwal
DFI | Director of Finance/CFO | 30 | Dec. 31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 23-09-28 | |
Shweta Jalan
BRD | Director/Board Member | 48 | Nov. 08 |
Director/Board Member | 62 | Nov. 08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.01% | 117 M€ | +1.11% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 659.7 | +1.99% | 122,136 |
24-04-25 | 646.8 | +0.83% | 271,782 |
24-04-24 | 641.5 | -0.61% | 47,789 |
24-04-23 | 645.4 | +1.26% | 70,579 |
24-04-22 | 637.4 | -1.10% | 97,371 |
End-of-day quote NSE India S.E., April 25, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.73% | 2.01B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- SUVENPHAR Stock